NOT KNOWN FACTUAL STATEMENTS ABOUT ORAL SYRINGE 5ML

pentobarbital will reduce the level or impact of buprenorphine, prolonged-acting injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Sufferers who transfer to buprenorphine prolonged-acting injection from transmucosal buprenorphine coadministered with CYP3A4 inducers must be monitored to be s